Latest Breaking News On - ஸ்டம்ப் ஜான் நிறுவனம் ஆஃப் தோல் நோய் - Page 1 : vimarsana.com

 E-Mail Note: this paper is being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and is being published in The Lancet Rheumatology. Please credit both the congress and the journal in your stories A new study presented at this year s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, shows that the antibody - but not the T-cell - response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant methotrexate. In contrast, antibody and T cell responses are preserved in patients taking biological drugs such as tumour necrosis factor (TNF) inhibitors.

United statesUnited kingdomCity ofSatveer mahilCatherine smithKing college londonEuropean congressSt john institute of dermatologyClinical microbiologyInfectious diseasesLancet rheumatologyNorth americaProfessor catherine smithCollege londonஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்